News Daily News Potential Genetic Link Between Platelet Activity and Cardiovascular Disease Identified Michael O'Riordan September 22, 2016
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Conference News PCR London Valves 2016 Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon Shelley Wood September 20, 2016
News Daily News Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins Todd Neale September 19, 2016
News Daily News Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late L.A. McKeown September 16, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Daily News The Benefits of Exercise Aren’t Affected By Family History of Heart Disease Yael L. Maxwell September 08, 2016
News Daily News Patient-Level Data Supports PCI for Some Patients with Unprotected Left Main Disease Yael L. Maxwell September 07, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Cardiac MRI and SPECT Reduce Unnecessary Angiograms vs Guideline-Directed Care in Suspected CAD: CE-MARC2 Michael O'Riordan August 29, 2016
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Conference News ESC 2016 Treating Sleep Apnea Fails to Boost Outcomes in Patients With CVD: SAVE Trial Todd Neale August 28, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Daily News Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients L.A. McKeown August 24, 2016
News Opinion Editor's Corner ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness Shelley Wood August 24, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016